Advertisement
Advertisement

GLPG

GLPG logo

Galapagos NV

26.58
USD
+0.05
+0.18%
Mar 07, 15:59 UTC -5
Closed
exchange

After-Market

26.58

0
0.00%

Galapagos NV Profile

About

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.

Info & Links

CEO

Paul Stoffels

Headquarters

GEN DE WITTELAAN L11 A3
MECHELEN, C9 2800, BELGIUM

Sector

Medical

Auditor

Deloitte Bedrijfsrevisoren

Share holders

--

Employees

1,338

Galapagos NV Statistics

Valuation Measures

Market Capitalization2

1.75B

Enterprise Value

1.69B

Enterprise Value/EBITDA(ttm)

-7.59

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

72.39%

Operating Margin(ttm)

--

Profit Margin(ttm)

-23.79%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-7.98%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

309.95M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

300.14M

EBITDA(ttm)3

-222.03M

Net Income Available to Common(ttm)

-138.50M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.21

52-Week Change

-22.87%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

63.98M

% Held by Insiders

2.91%

% Held by Institutions

32.46%

Balance Sheet

Total Cash(mrq)

3.42B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

3.76M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

9.81%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement